Inhaled colistin in elderly patients with bronchiectasis and chronic bronchial infection with pseudomonas Source: Annual Congress 2012 - Management of severe respiratory infections Year: 2012
Treatment of patients with bronchial asthma and latent chlamydophila pneumoniae and mycoplasma pneumoniae infections by a doxycycline Source: Eur Respir J 2002; 20: Suppl. 38, 159s Year: 2002
Corticosteroid therapy combined with antibiotics for severe Streptococcus pneumoniae pneumonia in ventilated piglets Source: International Congress 2019 – Clinical challenges in respiratory infection Year: 2019
Nasopharyngeal carriage of Streptococcus pneumoniae by children with underlying pulmonary diseases Source: Eur Respir J 2005; 26: Suppl. 49, 167s Year: 2005
Inhaled drugs as risk factors for community-acquired pneumonia Source: Annual Congress 2010 - The spectrum of lower respiratory tract infections: risk factors of poor outcome and diagnostic tools Year: 2010
Mycoplasma pneumoniae infection of airways in patients with exacerbations of bronchial asthmaSource: Eur Respir J 2006; 28: Suppl. 50, 237s Year: 2006
Inhaled antibiotics in chronic airway infections Source: Eur Respir Monogr 2017; 75: 57-79 Year: 2017
Chlamydia pneumoniae infection in patients with bronchial asthma Source: Eur Respir J 2004; 24: Suppl. 48, 52s Year: 2004
Infection with mycoplasma pneumoniae and chlamydia pneumoniae in non-allergic late-onset asthma Source: Eur Respir J 2006; 28: Suppl. 50, 376s Year: 2006
Chlamydia pneumoniae infection and severe asthma exacerbations Source: Eur Respir J 2002; 20: Suppl. 38, 221s Year: 2002
Inhaled drugs as risk factors for community-acquired pneumonia Source: Eur Respir J 2010; 36: 1080-1087 Year: 2010
Levofloxacin non-susceptible streptococcus pneumoniae in community-acquired respiratory infection; prevalence and risk factors Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia Year: 2007
Role of inhaled corticosteroids on recurrent bronchial infection by potentially pathogenic bacteria in patients with COPD Source: Virtual Congress 2020 – COPD : inhaled corticosteroids, bronchodilators and eosinophils Year: 2020
Antibiotics and new guidelines for the treatment of lower respiratory tract infections Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=175 Year: 2004
A study of the prevalence of streptococcus pneumoniae serotypes in patients hospitalised for community-acquired pneumonia Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues Year: 2016
Inhaled corticosteroids and the increased risk of non-tuberculous mycobacteria infection Source: International Congress 2019 – Exploring the link between inhaled corticosteroids and respiratory infection Year: 2019
Inhaled corticosteroid use and its association with Pseudomonas aeruginosa infection in COPD Source: Virtual Congress 2021 – Inhaled treatments for COPD: clinical trials and real-world studies Year: 2021
The risk of mycobacterial infections associated with inhaled corticosteroid use Source: Eur Respir J, 50 (3) 1700037; 10.1183/13993003.00037-2017 Year: 2017
Chlamydophila pneumoniae and mycoplasma pneumoniae infection of airways and exacerbations of bronchoobstructive diseases Source: Annual Congress 2008 - Lower respiratory tract infection: from outbreak to prognostic tests Year: 2008
Risk factors for MRSA staphylococcal carriage in children with chronic allergic diseases Source: Eur Respir J 2006; 28: Suppl. 50, 265s Year: 2006